High court should reject vaccine suits
POINT OF VIEW: Drug labeling liability
Comments
10
BY SALLY C. PIPES
Published: November 12, 2008
The Supreme Court recently heard arguments in a case likely to have profound effects on how vaccines are marketed, distributed and developed. The court’s verdict could affirm the existing regulatory framework for testing and labeling vaccines. That would be good news, as vaccines are among the most effective medical advancements in history.
A ruling in the other direction, though, would enable a torrent of frivolous lawsuits, threatening future vaccine development and cutting off patient access to medicines. The case, Wyeth v. Levine, involves a Vermont woman who claims the manufacturer of the anti-nausea drug Phenergan failed to sufficiently warn her doctor of the dangers posed by one delivery method of the drug. The drug’s label was approved by the federal Food and Drug Administration. But a lower court ruled that the label wasn’t amply informative and that the plaintiff was owed damages. The question facing the court, then, is whether federal law trumps state law in the area of drug-labeling requirements. If it does, the FDA would have the final word on what needs to be included in a label. If it doesn’t, then a private citizen could sue for labeling liability even if the firm in question complied with federal law. An anti-pre-emption decision would cause an uptick in litigation against drug makers, particularly vaccine manufacturers. Vaccines have proven susceptible to unfounded medical scare stories. Witness the high-profile campaign linking the measles-mumps-rubella vaccine with autism, led by ex-Playboy playmate Jenny McCarthy. McCarthy’s gripes are unfounded. More than 20 scientific studies have found that the vaccine doesn’t raise a child’s risk for autism. But her efforts have scared countless parents from getting their kids inoculated. According to the Centers for Disease Control and Prevention, there were 131 reported cases of measles during the first seven months of 2008. That’s the highest total in more than a decade. Ninety-five of those cases were in children who were eligible for vaccination but didn’t receive a shot. Determining what health risks are sufficiently probable to warrant a warning is a technical process, best conducted by experts. That’s why the FDA, which has some of the world’s best-trained scientists, is so well-suited for the task. The average American isn’t so suited. Without pre-emption, that’s who would be given the responsibility — jurors and judges. Trial lawyers know this. They’ll start fishing for plaintiffs in hopes of winning big-money judgments. The threat of frivolous litigation will lead many vaccine manufacturers to halt production. As a study by Vanderbilt economist Kip Viscusi in the Stanford Law Review found, "liability hazards led many firms to exit the vaccine market.” Federal pre-emption would ensure uniformity in warning labels and guarantee that all Americans have equal access to vaccine information. For the sake of patients, physicians, and public health, the Supreme Court should affirm pre-emption. Pipes is president and CEO of the Pacific Research Institute ( www.pacificresearch.org).
Related Topics:
Health and Fitness, Medicine, Contagious and Infectious Diseases, Civil Trials, Trials, Vaccines, Medical Treatments and Procedures

Prev

Something to say about this topic? Submit a Letter to the Editor online
Thank you for joining our conversations on newsok. We encourage your discussions but ask that you stay within the bounds of our terms and conditions. Please help us by reporting comments that violate these guidelines. To review our rules of engagement, go to Commenting and posting policy.
Log in below or sign up (it's free).
I cannot see a movie in a theater – the pain is just too great. Sitting through a church service is quite painful. My ability to exercise is limited, and has cost me opportunities to be involved in Boy Scout activities with my son. My doctor keeps telling me that I need to get a colonoscopy, but I cannot go even one day without ibuprofen (600 mg 2 to 6 times a day), much less the requisite 2 weeks. The ibuprofen combined with a muscle relaxant tear my stomach up so badly without food that I gained 45 lbs. I have lost 20 of it, but really struggle to avoid further weight gain.
It appears I will have to deal with this pain for the rest of my life. I would gladly trade any recovery I receive, and much more, just to live without the pain in the future.
My reaction is very rare. It is hardly worth mentioning, unless it happens to you. Then you wonder why no one ever warned you about such problems. I don’t want to but vaccine companies out of business, and the federal claims process was set up to prevent that, but unfortunately, money is the only way we have of compensating people for injuries.
http://www.hrsa.gov/vaccinecompensation/statistics_report.htm shows that more than $916 MILLION dollars have been paid to people injured by vaccines, not just those claiming autism, because every single case there has been dismissed.
The fact is, the federal government already paid out nearly a billion dollars of tax money in payments to people who have been vaccine injured. This pre-emption is just a continuation of the lobbying attempted in the PATRIOT act to completely remove any liability that drug companies have for their product. You see how far that got China with their melamine problems...why do Americans want to set up the US for the same issues? Without liability, there is little economic reason to slow down and consider all the implications of a new class of drugs. Or even the introduction of new drugs with previously prescribed ones.
Fifteen of the patients (11%) were hospitalized, including four children aged
Fifteen of the patients (11%) were hospitalized, including four children aged